These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 27573381

  • 1. Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma.
    Kucharz J, Giza A, Dumnicka P, Kuzniewski M, Kusnierz-Cabala B, Bryniarski P, Herman R, Zygulska AL, Krzemieniecki K.
    Med Oncol; 2016 Oct; 33(10):109. PubMed ID: 27573381
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.
    Bourlon MT, Gao D, Trigero S, Clemons JE, Breaker K, Lam ET, Flaig TW.
    Cancer Med; 2016 Dec; 5(12):3386-3393. PubMed ID: 27758076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib.
    Bolzacchini E, Giordano M, Bertù L, Bregni M, Nigro O, Galli L, Antonuzzo A, Artale S, Barzaghi S, Danova M, Torchio M, Pinotti G, Dentali F.
    Tumori; 2022 Oct; 108(5):502-509. PubMed ID: 34296630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma.
    Park SJ, Lee JL, Park I, Park K, Ahn Y, Ahn JH, Lee DH, Ahn S, Song C, Hong JH, Kim CS, Ahn H.
    Chemotherapy; 2012 Oct; 58(6):468-74. PubMed ID: 23548259
    [Abstract] [Full Text] [Related]

  • 13. Co-occurring adverse events enable early prediction of progression-free survival in metastatic renal cell carcinoma patients treated with sunitinib: a hypothesis-generating study.
    Kucharz J, Dumnicka P, Kuzniewski M, Kusnierz-Cabala B, Herman RM, Krzemieniecki K.
    Tumori; 2015 Oct; 101(5):555-9. PubMed ID: 26045121
    [Abstract] [Full Text] [Related]

  • 14. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
    Beuselinck B, Vano YA, Oudard S, Wolter P, De Smet R, Depoorter L, Teghom C, Karadimou A, Zucman-Rossi J, Debruyne PR, Van Poppel H, Joniau S, Lerut E, Strijbos M, Dumez H, Paridaens R, Van Calster B, Schöffski P.
    BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan.
    Miyake H, Miyazaki A, Harada K, Fujisawa M.
    Med Oncol; 2014 Jun; 31(6):978. PubMed ID: 24793747
    [Abstract] [Full Text] [Related]

  • 17. C-reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib.
    Fujita T, Iwamura M, Ishii D, Tabata K, Matsumoto K, Yoshida K, Baba S.
    Int J Urol; 2012 Oct; 19(10):908-13. PubMed ID: 22671963
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency.
    Kim KH, Kim HY, Kim HR, Sun JM, Lim HY, Lee HJ, Lee S, Bae WK, Rha SY, Korean Cancer Study Group, Genitourinary & Gynecology Cancer Committee.
    Eur J Cancer; 2014 Mar; 50(4):746-52. PubMed ID: 24332573
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.
    Paglino C, Imarisio I, Ganini C, Morbini P, Vercelli A, Bregant C, Porta C.
    Future Oncol; 2012 Dec; 8(12):1605-12. PubMed ID: 23231522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.